Malik et al., 2015 - Google Patents
Genetics of CD33 in Alzheimer's disease and acute myeloid leukemiaMalik et al., 2015
View HTML- Document ID
- 6023329546791697218
- Author
- Malik M
- Chiles III J
- Xi H
- Medway C
- Simpson J
- Potluri S
- Howard D
- Liang Y
- Paumi C
- Mukherjee S
- Crane P
- Younkin S
- Fardo D
- Estus S
- Publication year
- Publication venue
- Human molecular genetics
External Links
Snippet
The CD33 single-nucleotide polymorphism (SNP) rs3865444 has been associated with the risk of Alzheimer's disease (AD). Rs3865444 is in linkage disequilibrium with rs12459419 which has been associated with efficacy of an acute myeloid leukemia (AML) …
- 206010001897 Alzheimer's disease 0 title abstract description 101
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Malik et al. | Genetics of CD33 in Alzheimer's disease and acute myeloid leukemia | |
| Eissman et al. | Sex differences in the genetic architecture of cognitive resilience to Alzheimer’s disease | |
| Leisegang et al. | Pleiotropic effects of laminar flow and statins depend on the Krüppel-like factor-induced lncRNA MANTIS | |
| Lacour et al. | Genome-wide significant risk factors for Alzheimer’s disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment | |
| Miranda et al. | Excess synaptojanin 1 contributes to place cell dysfunction and memory deficits in the aging hippocampus in three types of Alzheimer’s disease | |
| McDonald et al. | Lesions from patients with sporadic cerebral cavernous malformations harbor somatic mutations in the CCM genes: evidence for a common biochemical pathway for CCM pathogenesis | |
| Ridge et al. | Alzheimer’s disease: analyzing the missing heritability | |
| Gijselinck et al. | Loss of TBK1 is a frequent cause of frontotemporal dementia in a Belgian cohort | |
| Sherva et al. | Genome‐wide association study of the rate of cognitive decline in Alzheimer's disease | |
| Huijgen et al. | Cardiovascular risk in relation to functionality of sequence variants in the gene coding for the low-density lipoprotein receptor: a study among 29 365 individuals tested for 64 specific low-density lipoprotein-receptor sequence variants | |
| Malik et al. | CD33 Alzheimer's risk-altering polymorphism, CD33 expression, and exon 2 splicing | |
| Yu et al. | Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration | |
| Alencar et al. | ARMC5 mutations are a frequent cause of primary macronodular adrenal hyperplasia | |
| Love-Gregory et al. | Common CD36 SNPs reduce protein expression and may contribute to a protective atherogenic profile | |
| Hageman et al. | A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration | |
| Dahlgren et al. | Do alcohol-dependent individuals with DRD2 A1 allele have an increased risk of relapse? A pilot study | |
| Teltsh et al. | Oxytocin and vasopressin genes are significantly associated with schizophrenia in a large Arab-Israeli pedigree | |
| Weterman et al. | A frameshift mutation in LRSAM1 is responsible for a dominant hereditary polyneuropathy | |
| Swaminathan et al. | Analysis of copy number variation in Alzheimer’s disease in a cohort of clinically characterized and neuropathologically verified individuals | |
| Sulkava et al. | Melatonin receptor type 1A gene linked to Alzheimer’s disease in old age | |
| Park et al. | NUP107 mutations in children with steroid-resistant nephrotic syndrome | |
| Oshima et al. | Search and insights into novel genetic alterations leading to classical and atypical Werner syndrome | |
| Walz et al. | Surgical outcome in mesial temporal sclerosis correlates with prion protein gene variant | |
| Zou et al. | Sex-dependent association of a common low-density lipoprotein receptor polymorphism with RNA splicing efficiency in the brain and Alzheimer’s disease | |
| Lindahl-Jacobsen et al. | Effects of the APOE ε 2 allele on mortality and cognitive function in the oldest old |